Your browser doesn't support javascript.
Predictors of mortality in COVID-19 patients at Kinshasa Medical Center and a survival analysis: a retrospective cohort study.
Nlandu, Yannick; Mafuta, Danny; Sakaji, Junior; Brecknell, Melinda; Engole, Yannick; Abatha, Jessy; Nkumu, Jean-Robert; Nkodila, Aliocha; Mboliassa, Marie-France; Tuyinama, Olivier; Bena, Dauphin; Mboloko, Yves; Kobo, Patrick; Boloko, Patrick; Tshangu, Joseph; Azika, Philippe; Kanku, Jean-Pierre; Mafuta, Pally; Atantama, Magloire; Mavungu, Jean-Michel; Kitenge, Rosita; Sehli, Asma; Van Eckout, Karel; Mukuku, Cathy; Bergeret, Léo; Benchetritt, David; Kalifa, Golan; Rodolphe, Ahmed; Bukabau, Justine.
  • Nlandu Y; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo. yannicknlandu@yahoo.fr.
  • Mafuta D; Nephrology Unit, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo. yannicknlandu@yahoo.fr.
  • Sakaji J; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Brecknell M; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Engole Y; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Abatha J; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Nkumu JR; Nephrology Unit, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Nkodila A; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Mboliassa MF; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Tuyinama O; Faculty of Public Health, Lomo University, Kinshasa, Democratic Republic of the Congo.
  • Bena D; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Mboloko Y; Nephrology Unit, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo.
  • Kobo P; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Boloko P; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Tshangu J; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Azika P; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Kanku JP; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Mafuta P; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Atantama M; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Mavungu JM; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Kitenge R; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Sehli A; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Van Eckout K; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Mukuku C; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Bergeret L; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Benchetritt D; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Kalifa G; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Rodolphe A; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
  • Bukabau J; Intensive Care Unit, Kinshasa Medical Center, Kinshasa, Democratic Republic of the Congo.
BMC Infect Dis ; 21(1): 1272, 2021 Dec 20.
Article in English | MEDLINE | ID: covidwho-1636004
ABSTRACT

BACKGROUND:

Despite it being a global pandemic, there is little research examining the clinical features of severe COVID-19 in sub-Saharan Africa. This study aims to identify predictors of mortality in COVID-19 patients at Kinshasa Medical Center (KMC).

METHODS:

In this retrospective, observational, cohort study carried out at the Kinshasa Medical Center (KMC) between March 10, 2020 and July 10, 2020, we included all adult inpatients (≥ 18 years old) with a positive COVID-19 PCR result. The end point of the study was survival. The study population was dichotomized into survivors and non-survivors group. Kaplan-Meier plot was used for survival analyses. The Log-Rank test was employed to compare the survival curves. Predictors of mortality were identified by Cox regression models. The significance level of p value was set at 0.05.

RESULTS:

432 patients with confirmed COVID-19 were identified and only 106 (24.5%) patients with moderate, severe or critical illness (mean age 55.6 ± 13.2 years old, 80.2% were male) were included in this study, of whom 34 (32%) died during their hospitalisation. The main complications of the patients included ARDS in 59/66 (89.4%) patients, coagulopathy in 35/93 (37.6%) patients, acute cardiac injury in 24/98 (24.5%) patients, AKI in 15/74 (20.3%) patients and secondary infection in 12/81 (14.8%) patients. The independent predictors of mortality were found to be age [aHR 1.38; 95% CI 1.10-1.82], AKI stage 3 [aHR 2.51; 95% CI 1.33-6.80], proteinuria [aHR 2.60; 95% CI 1.40-6.42], respiratory rate [aHR 1.42; 95% CI 1.09-1.92] and procalcitonin [aHR 1.08; 95% CI 1.03-1.14]. The median survival time of the entire group was 12 days. The cumulative survival rate of COVID-19 patients was 86.9%, 65.0% and 19.9% respectively at 5, 10 and 20 days. Levels of creatinine (p = 0.012), were clearly elevated in non-survivors compared with survivors throughout the clinical course and increased deterioration.

CONCLUSION:

Mortality rate of COVID-19 patients is high, particularly in intubated patients and is associated with age, respiratory rate, proteinuria, procalcitonin and acute kidney injury.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adolescent / Adult / Aged / Humans / Male / Middle aged Country/Region as subject: Africa Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S12879-021-06984-x

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adolescent / Adult / Aged / Humans / Male / Middle aged Country/Region as subject: Africa Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S12879-021-06984-x